Hospital Mater Dei's EBIT per Share for the
three
months ended in Mar. 2026 was R$345.78.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was R$346.81.
During the past 12 months, the average EBIT per Share Growth Rate of Hospital Mater Dei was 35.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 4.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 16.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Hospital Mater Dei's EBIT per Share or its related term are showing as below:
BSP:MATD3'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 3.5 Med: 14.8 Max: 36.5
Current: 4.1
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Hospital Mater Dei was 36.50% per year. The lowest was 3.50% per year. And the median was 14.80% per year.
BSP:MATD3's 3-Year EBIT Growth Rate is ranked worse than 63.02% of 530
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs BSP:MATD3: 4.10
Hospital Mater Dei (BSP:MATD3) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Hospital Mater Dei EBIT per Share Related Terms
Hospital Mater Dei EBIT per Share Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$346.81
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei (BSP:MATD3) has a EBIT per Share of R$346.81 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hospital Mater Dei and its competitors. According to the industry distribution chart, Hospital Mater Dei ranks #334 out of 530 companies in the Healthcare Providers & Services industry, placing it in the top 63%.
Is Hospital Mater Dei's EBIT per Share too high?
Hospital Mater Dei's current EBIT per Share is R$346.81. Based on the distribution chart, Hospital Mater Dei ranks #334 out of 530 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #334 out of 530 companies for EBIT per Share. This places Hospital Mater Dei in the lower half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 530 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current EBIT per Share is R$346.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Possible Value Trap. The stock's GF Value™ is R$2,813.62, compared to a current price of R$4.88 — trading 99.8% below its estimated fair value. The current EBIT per Share is R$346.81. Hospital Mater Dei's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current EBIT per Share is R$346.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.88 is trading 99.8% below its estimated GF Value™ of R$2,813.62.
GuruFocus considers Hospital Mater Dei to be Possible Value Trap.
Key valuation signals for BSP:MATD3:
EBIT per Share: R$346.81
GF Value™: R$2,813.62 vs. price of R$4.88 (99.8% below fair value)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
75GF Score
Get the complete analysis for BSP:MATD3
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
